CareDx (CDNA) Tops Q2 EPS by 3c

CareDx (NASDAQ: CDNA) reported Q2 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $17.8 million versus the consensus estimate of $15.49 million.

Guidance:

For the full year 2018, CareDx expects revenue to be in the range of $68 million to $70 million (previously $64 million to $66 million), with adjusted EBITDA profitability expected during the current half of the year

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'
• Qualcomm investor day to detail data center plans Wednesday